Pricing
Login
Home
Charts
Search
Watchlist
Products

Accent Microcell Ltd

ACCENTMIC
₹584.85-2.40%20 Nov 2026
Reports
Pharma Formulations

Accent Microcell Ltd

ACCENTMIC
₹584.85
-2.40%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,403Cr
Close
Close Price
₹584.85
Industry
Industry
Pharma Formulations
PE
Price To Earnings
24.43
PS
Price To Sales
3.65
Revenue
Revenue
₹385Cr
Rev Gr TTM
Revenue Growth TTM
38.35%
PAT Gr TTM
PAT Growth TTM
64.15%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Revenue
RevenueCr
107139126139139210175
Growth YoY
Revenue Growth YoY%
17.9-0.110.651.325.4
Expenses
ExpensesCr
88119107115115177133
Operating Profit
Operating ProfitCr
19201923243341
OPM
OPM%
17.314.414.916.717.215.623.6
Other Income
Other IncomeCr
2233343
Interest Expense
Interest ExpenseCr
1000000
Depreciation
DepreciationCr
2222232
PBT
PBTCr
19222226263744
Tax
TaxCr
33386911
PAT
PATCr
14161617182631
Growth YoY
PAT Growth YoY%
16.83.39.755.472.2
NPM
NPM%
13.211.613.112.013.012.317.8
EPS
EPS₹
10.49.47.87.57.811.013.0
QuarterSep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Revenue
RevenueCr
107139126139139210175
Growth YoY
Revenue Growth YoY%
17.9-0.110.651.325.4
Expenses
ExpensesCr
88119107115115177133
Operating Profit
Operating ProfitCr
19201923243341
OPM
OPM%
17.314.414.916.717.215.623.6
Other Income
Other IncomeCr
2233343
Interest Expense
Interest ExpenseCr
1000000
Depreciation
DepreciationCr
2222232
PBT
PBTCr
19222226263744
Tax
TaxCr
33386911
PAT
PATCr
14161617182631
Growth YoY
PAT Growth YoY%
16.83.39.755.472.2
NPM
NPM%
13.211.613.112.013.012.317.8
EPS
EPS₹
10.49.47.87.57.811.013.0

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
114131133166197246265349385
Growth
Revenue Growth%
15.30.925.019.124.47.831.938.4
Expenses
ExpensesCr
108123122153178206223292310
Operating Profit
Operating ProfitCr
6911131939425774
OPM
OPM%
4.96.78.17.89.616.115.816.219.3
Other Income
Other IncomeCr
642223677
Interest Expense
Interest ExpenseCr
333331010
Depreciation
DepreciationCr
334444455
PBT
PBTCr
56681537445881
Tax
TaxCr
121236111420
PAT
PATCr
44561230334457
Growth
PAT Growth%
15.315.022.7107.6146.69.632.664.2
NPM
NPM%
3.23.23.63.66.212.312.512.614.8
EPS
EPS₹
8.49.73.74.69.517.714.918.623.9
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
114131133166197246265349385
Growth
Revenue Growth%
15.30.925.019.124.47.831.938.4
Expenses
ExpensesCr
108123122153178206223292310
Operating Profit
Operating ProfitCr
6911131939425774
OPM
OPM%
4.96.78.17.89.616.115.816.219.3
Other Income
Other IncomeCr
642223677
Interest Expense
Interest ExpenseCr
333331010
Depreciation
DepreciationCr
334444455
PBT
PBTCr
56681537445881
Tax
TaxCr
121236111420
PAT
PATCr
44561230334457
Growth
PAT Growth%
15.315.022.7107.6146.69.632.664.2
NPM
NPM%
3.23.23.63.66.212.312.512.614.8
EPS
EPS₹
8.49.73.74.69.517.714.918.623.9
Sales CAGR
1 Year32%
3 Years21%
5 Years21%
TTM-
EBITDA CAGR
1 Year35%
3 Years44%
5 Years40%
TTM-
PAT CAGR
1 Year33%
3 Years53%
5 Years56%
TTM-
Avg. ROCE
1 Year21%
3 Years22%
5 Years22%
TTM27%
CFO / EBITDA
1 Year33%
3 Years40%
5 Years45%
TTM-

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
444131321212424
Reserves
ReservesCr
1721221937143174252280
Current Liabilities
Current LiabilitiesCr
3434355454383044
Non Current Liabilities
Non Current LiabilitiesCr
18181997333
Total Liabilities
Total LiabilitiesCr
73778195111205228322346
Current Assets
Current AssetsCr
4348506478163154155
Non Current Assets
Non Current AssetsCr
30293131334174167
Total Assets
Total AssetsCr
73778195111205228322346
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
444131321212424
Reserves
ReservesCr
1721221937143174252280
Current Liabilities
Current LiabilitiesCr
3434355454383044
Non Current Liabilities
Non Current LiabilitiesCr
18181997333
Total Liabilities
Total LiabilitiesCr
73778195111205228322346
Current Assets
Current AssetsCr
4348506478163154155
Non Current Assets
Non Current AssetsCr
30293131334174167
Total Assets
Total AssetsCr
73778195111205228322346

Cash Flow

Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
655158112519
Investing Cash Flow
Investing Cash FlowCr
-4-2-6-4-4-82-9-49
Financing Cash Flow
Financing Cash FlowCr
-1-2-2-10-472-1436
Net Cash Flow
Net Cash FlowCr
11-31-1126
Free Cash Flow
Free Cash FlowCr
230114-2-12-68
CFO To PAT
CFO To PAT%
158.1126.5104.9252.361.937.574.642.5
CFO To EBITDA
CFO To EBITDA%
102.460.447.1114.640.028.758.932.9
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
655158112519
Investing Cash Flow
Investing Cash FlowCr
-4-2-6-4-4-82-9-49
Financing Cash Flow
Financing Cash FlowCr
-1-2-2-10-472-1436
Net Cash Flow
Net Cash FlowCr
11-31-1126
Free Cash Flow
Free Cash FlowCr
230114-2-12-68
CFO To PAT
CFO To PAT%
158.1126.5104.9252.361.937.574.642.5
CFO To EBITDA
CFO To EBITDA%
102.460.447.1114.640.028.758.932.9

Ratios

Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5174028521,403
Price To Earnings
Price To Earnings
17.112.219.424.4
Price To Sales
Price To Sales
2.11.52.43.6
Price To Book
Price To Book
3.22.13.15.1
EV To EBITDA
EV To EBITDA
11.68.414.718.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
23.926.522.223.622.827.627.828.328.3
OPM
OPM%
4.96.78.17.89.616.115.816.219.3
NPM
NPM%
3.23.23.63.66.212.312.512.614.8
ROCE
ROCE%
16.618.016.419.023.721.322.521.326.5
ROE
ROE%
17.316.618.018.424.318.417.015.918.7
ROA
ROA%
5.05.46.06.211.114.714.513.616.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5174028521,403
Price To Earnings
Price To Earnings
17.112.219.424.4
Price To Sales
Price To Sales
2.11.52.43.6
Price To Book
Price To Book
3.22.13.15.1
EV To EBITDA
EV To EBITDA
11.68.414.718.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
23.926.522.223.622.827.627.828.328.3
OPM
OPM%
4.96.78.17.89.616.115.816.219.3
NPM
NPM%
3.23.23.63.66.212.312.512.614.8
ROCE
ROCE%
16.618.016.419.023.721.322.521.326.5
ROE
ROE%
17.316.618.018.424.318.417.015.918.7
ROA
ROA%
5.05.46.06.211.114.714.513.616.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,8411,5931,4821,4031,3821,1121,079
Close PriceClose₹1,655.402,312.00512.65584.85209.27469.95320.15
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE33.9925.8724.4330.6496.7052.83
Price To SalesPS4.144.042.803.654.607.181.64
RevenueRevenueCr444395529385301155656
Revenue Growth TTMRev Gr TTM%15.2%10.6%12.6%38.4%6.4%8.7%14.3%
PAT Growth TTMPAT Gr TTM%27.3%64.3%1.0%64.2%-26.6%31.4%-55.0%
Market CapitalizationMkt CapCr1,8411,5931,4821,4031,3821,1121,079
Close PriceClose₹1,655.402,312.00512.65584.85209.27469.95320.15
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE33.9925.8724.4330.6496.7052.83
Price To SalesPS4.144.042.803.654.607.181.64
RevenueRevenueCr444395529385301155656
Revenue Growth TTMRev Gr TTM%15.2%10.6%12.6%38.4%6.4%8.7%14.3%
PAT Growth TTMPAT Gr TTM%27.3%64.3%1.0%64.2%-26.6%31.4%-55.0%
Annual Reports
FY2026
FY2025
FY2024
Quarterly Reports
FY2026
Sep 26
ResultPPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Sep 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
ResultPPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Sep 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Load More
Interviews